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Abstract The nuclear localization signal (NLS) of the SV40
large T antigen efficiently induces nuclear entry of proteins. We
have developed a strategy for covalent coupling of one or a
controlled number of NLS peptides to plasmid DNA at a specific
site by triple helix formation. A psoralen-oligonucleotide-NLS
peptide conjugate was synthesized and characterized by proteo-
lysis with trypsin. This conjugate was used to covalently
associate one NLS peptide to plasmid DNA by triple helix
formation and photoactivation. The oligonucleotide-NLS peptide
conjugate interacted with the NLS-receptor importin K. The
reporter gene was expressed after transfection of the modified
plasmid in NIH 3T3 cells, indicating no loss of the gene
expression functionality of the plasmid. On the other hand, no
increase in expression was observed as a result of the NLS
peptide. This site-specific coupling technology can be used to
couple to a plasmid other ligands targeting to a specific receptor.
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1. Introduction
Plasmids used for non-viral gene therapy are generally de-
livered as a complex with a variety of chemical or biochemical
vectors such as cationic lipids, in order to obtain maximal
transfection e⁄ciency [1]. Non-viral gene transfer with cati-
onic lipids can be divided into several steps including internal-
ization of the DNA via fusion at the cellular membrane or via
endocytosis, followed by plasmid di¡usion to the nuclear en-
velope and entry into the nucleus, probably through the pore
complexes [2,3]. One of the steps limiting the e⁄ciency of non-
viral gene transfer into non-dividing cells is the entry of plas-
mid DNA from the cytoplasm into the nucleus [2,4].
The role of signal sequences for protein import into the
nucleus is well documented [5,6]. Proteins larger than 60
kDa are excluded from the nucleus unless they harbor a nu-
clear localization signal (NLS). The NLS peptides usually
comprise stretches of highly basic amino acids [5]. Among
the di¡erent NLSs, the NLS of the simian virus 40 (SV40)
large T antigen has been extensively studied. This short pep-
tide possesses ¢ve basic amino acids and it e⁄ciently induces
nuclear targeting when conjugated to a non-karyophilic pro-
tein of molecular weight up to 465 kDa [7]. Karyopherins are
involved in nuclear protein import through association with
nuclear localization signals in the cytoplasm, then binding to
the nuclear pore complex [8]. The 58 kDa mouse karyopherin
K (called importin K or m-importin) binds to the NLS se-
quence and then interacts with karyopherin L (also called
importin L). The resulting complex binds to the nuclear
pore [9], and is translocated through the pore in a mechanism
involving the small GTPase Ran and other proteins [10].
In order to determine if the nuclear import of plasmid
DNA can be increased by association with the protein import
machinery, it is straightforward to covalently link a NLS pep-
tide to DNA. Non-speci¢c covalent linkage of multiple NLS
peptides on linearized or circular DNA has been described
[11,12]. However, in these strategies, NLS peptides were asso-
ciated with non-speci¢c sites on DNA, leading to the loss of
gene expression. In the present work, we have developed a
new methodology to covalently associate a cationic NLS pep-
tide with plasmid DNA at a speci¢c site on the plasmid, by
triple helix formation. We report here the synthesis and char-
acterization of these conjugates. This site-speci¢c coupling
technology can be used for other purposes, for instance to
couple to a plasmid other ligands targeting to a speci¢c re-
ceptor.
2. Materials and methods
2.1. Analytical and semipreparative HPLC
Analytical and semipreparative HPLC were performed on a Merck-
Hitachi gradient pump equipped with an AS-2000A autosampler, a L-
6200A intelligent pump and a UV-Vis detector L-4000. Method 1:
The HPLC system used a C18 Vydac-218 TP 1022 (10 mm diameter)
column, with a gradient of acetonitrile/water 0.1% TFA (from 5 to
50% acetonitrile in 40 min) and a £ow rate of 7 ml/min. Detection was
by UV absorbance at 254 nm. Method 2: The HPLC system used a
250U4.6 mm C4 Vydac column and a gradient of 5^50% acetonitrile
over 40 min in 0.1 M triethylammonium acetate, pH 7.5 (£ow rate =
1 ml/min). Detection was by UV absorbance at 260 nm.
2.2. Peptide synthesis
The following peptide was synthesized: FmocK(NO-maleoyl)-
GAGPKKKRKV-NH2 which contains the wild type SV40 large T
NLS (PKKKRKV). The peptide was synthesized on an Applied Bio-
systems 431A automatic synthesizer using a Rink amide resin as solid
support and Fmoc strategy for amino acid assembly. Fmoc-Lys(NO-
maleoyl)OH was coupled manually in a separate £ask at the N-ter-
minal position of the peptide with a solution of dichloromethane
containing 4 equivalents of Fmoc-Lys(NO-maleoyl)OH, 4 equivalents
of BOP reagent and DIEA (pH 10). The peptide was cleaved from the
Rink resin in the usual manner and puri¢ed by semipreparative
HPLC, as described above (method 1). The ¢nal puri¢ed products
were analyzed by mass spectroscopy. FmocK(NO-maleoyl)-
GAGPKKKRKVNH2 ; HPLC: semipreparative, Rt = 22^27 min;
MH : 1499.
2.3. Oligonucleotide synthesis
Puri¢ed oligonucleotides with the sequence 5P-AAGGAGAG-
GAGGGAGGGAA-3P were purchased (Eurogentec, Seraing, Bel-
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gium). They were modi¢ed with either a thiol group at the 5P or 3P
terminus and a C6 spacer arm, or a psoralen group at the 5P terminus
and a C6 spacer arm. The abbreviations for these oligonucleotides are
given in Table 1.
2.4. Preparation of oligonucleotide-peptide conjugate
Lyophilized GA19-SH or Pso-GA19-SH oligonucleotides were dis-
solved in 0.1 M triethylammonium acetate, pH 7.5, at a concentration
of 0.5 mg/ml. Lyophilized FmocK(NO-maleoyl)GAGPKKKRKV-
NH2 peptide was dissolved in 100 mM triethylammonium acetate,
pH 7.5, at a concentration of 0.4 mg/ml. Equimolar quantities of
oligonucleotide and peptide were mixed at room temperature. The
reaction was monitored by HPLC, and, after 2 h, the conjugate was
puri¢ed by HPLC as described above (method 2).
2.5. Degradation of oligonucleotide-peptide conjugates by trypsin
The two oligonucleotide-peptide conjugates, GA19-NLS and Pso-
GA19-NLS, were analyzed after proteolytic treatment with trypsin.
Solutions containing 1 Wg of the conjugate in 7 Wl of water were
combined with 1 Wl of trypsin (5 mg/ml; Boehringer Mannheim),
1 Wl of 0.1 M Tris-HCl, pH 9 and 1 Wl of 0.5 M EDTA. After 1 h
of incubation at 37‡C, samples were analyzed on 15% denaturing
polyacrylamide gel and oligonucleotides were stained according to
the Bio-Rad Silver Stain kit (Bio-Rad).
2.6. Covalent association of oligonucleotide-peptide conjugate to
dsDNA
Plasmid pCMVLacZ (7257 bp) carries a cassette containing the
enhancer-promoter from the immediate-early gene of cytomegalovirus
(CMV) and the L-galactosidase gene. Plasmid DNA was puri¢ed us-
ing Wizard Megaprep kit (Promega, Madison, WI, USA). The se-
quence 3P-AAGGAGAGGAGGGAGGGAA-5P was cloned between
positions 7238 and 7256, out of the expression cassette. Plasmid
(3 pmol, 15 Wg) was incubated overnight at 37‡C with oligonucleo-
tide-peptide conjugate (150 pmol) in 0.1 M Tris-HCl, pH 7.5, 0.1 M
MgCl2. The mixture was cooled in an ice-water bath and illuminated
for 15 min in the dark using a sun lamp (Rad Free UV lamp, 365 nm;
Schleicher and Schuell, Ecquevilly, France). Excess oligonucleotide-
peptide conjugates were removed by ion-exchange chromatography
(PCR puri¢cation kit, Qiagen, Hilden, Germany).
2.7. Analysis of the photoproducts
Plasmids (3 pmol, 15 Wg) were incubated one night at 37‡C with
various concentrations of oligonucleotide-peptide conjugates in 0.1 M
Tris-HCl, pH 7.5, 0.1 M MgCl2. The mixture was cooled in an ice-
water bath and illuminated for 15 min in the dark using a sun lamp
(Rad Free UV lamp, 365 nm; Schleicher and Schuell, Ecquevilly,
France). The plasmid was then digested at 37‡C with MfeI and
SpeI endonucleases. Samples were electrophoresed on a denaturing
15% polyacrylamide gel and DNA was stained according to the
Bio-Rad Silver Stain kit (Bio-Rad).
2.8. Transgene expression studies
NIH 3T3 cells were obtained from the American Type Culture
Collection (ATCC CRL-1658). The cells were grown in Dulbecco’s
modi¢ed Eagle’s medium (DMEM, Gibco, Grand Island, NY, USA)
containing 4.5 g/l glucose, supplemented with 2 mM glutamine, 100
U/ml penicillin, 100 Wg/ml streptomycin and 10% fetal bovine serum.
Cells were grown at 37‡C in a 5% CO2/air incubator. One day before
transfection, 24 well culture plates were seeded with 90 000 cells per
well. Cationic lipid RPR 120535 [13] was used for the transfection
assays. Plasmids (20 ng/Wl) were diluted in 150 mM NaCl and mixed
with a cationic lipid solution (0.12 mM). The DNA/cationic lipid
complex was diluted in culture medium (DMEM) in the absence of
serum, and then added to the cells (0.5 Wg of DNA and 3 nmol lipid/
well). After 2 h at 37‡C in a 5% CO2/air incubator, 10% fetal bovine
serum was added to the cells. The cells were incubated for 48 h at
37‡C in a 5% CO2/air incubator. The cells were washed twice with
PBS and lysed with 250 Wl of cell culture lysis reagent (Promega,
Madison, WI, USA). The L-galactosidase expression was measured
according to the Lumigal L-galactosidase genetic reporter system
(Clontech, Palo Alto, CA, USA). Light emission was measured by
integration over 10 s using a Lumat LB9501 luminometer (EG and
G Berthold, Evry, France). Light emission was normalized to the
protein concentration determined using the Pierce BCA assay (Pierce,
Rockford, IL, USA).
2.9. Preparation of recombinant importin K-GST protein
Mouse importin K was cloned into pGEX-2T to produce a GST
(glutathione S-transferase) fusion protein: importin K-GST [8]. The
plasmid encoding the fusion protein was kindly provided by Dr. Y.
Yoneda (Osaka University Medical School, Osaka, Japan). Importin
K-GST was overexpressed and puri¢ed as previously described [8] and
kindly provided by Dr. F. Blanche and Dr. V. Thuillier (Rho“ne-Pou-
lenc Rorer Gencell, Vitry-sur-Seine, France).
2.10. Importin K binding assay
All assays were performed using importin K-GST recombinant pro-
tein. Binding to importin K was performed according to [12], with the
following modi¢cations: the bead slurry (80 Wl) was incubated with
2 Wg of oligonucleotide-peptide conjugate, in 0.5 ml of binding bu¡er,
for 30 min at room temperature. The beads were collected by centri-
fugation at 2000Ug for 30 s. The supernatant was removed, and 30 Wl
were used to analyze the presence of the unbound conjugate (this
fraction is called the unbound fraction). The beads were washed ¢ve
times with 0.5 ml of binding bu¡er and centrifuged at 2000Ug for 30
s. Finally, beads, corresponding to the bound fraction, were resus-
pended with 15 Wl of electrophoresis loading bu¡er (0.05% bromophe-
nol blue, 40% sucrose, 0.1 M EDTA pH 8, 0.5% sodium lauryl sul-
fate). The bound and unbound fractions were analyzed by
electrophoresis on a denaturing 15% polyacrylamide gel and DNA
was stained according to the Bio-Rad Silver Stain kit (Bio-Rad).
3. Results
3.1. Preparation of oligonucleotide-peptide conjugates
A peptide containing wild type SV40 large T NLS sequence
Fig. 1. HPLC chromatograms of oligonucleotide-NLS peptide con-
jugates. HPLC pro¢les of starting material and conjugate obtained
after 2 h of reaction are shown. The molecules were analyzed by re-
versed phase HPLC using method 2 described in Section 2.1 (ab-
sorption wavelength: 260 nm). A: Pso-GA19-SH oligonucleotide.
B: NLS peptide. C: Pso-GA19-NLS conjugate after 2 h of incuba-
tion.
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(NLS) was used. Scheme 1 illustrates the chemistry used to
prepare oligonucleotide-NLS peptide conjugates. The cou-
pling step involves reaction of the NLS peptide bearing a
maleimide group with the oligonucleotide bearing a nucleo-
philic thiol residue (oligonucleotide Pso-GA19-SH or GA19-
SH) [14]. Equimolar quantities of the two reagents were
used. The NLS peptide was chemically modi¢ed to bear a
Fmoc group. Since this group absorbs at 260 nm, the conju-
gation chemistry was easily monitored by reversed-phase
HPLC. After 2 h, the reaction was ¢nished (Fig. 1). The yield
of this reaction was 40% with oligonucleotide Pso-GA19-SH
and 75% with oligonucleotide GA19-SH, as shown by the al-
most complete disappearance of starting materials.
3.2. Characterization of oligonucleotide-peptide conjugates
The purity of the oligonucleotide-peptide conjugate was
con¢rmed by polyacrylamide gel electrophoresis. It appeared
as one major band (Fig. 2, lane 2). The presence of the pep-
tide residue within Pso-GA19-NLS conjugate was further con-
¢rmed by electrophoresis in denaturing polyacrylamide gel
and by proteolytic treatment using trypsin. Trypsin catalyzes
hydrolysis at the carboxyl side of lysine or arginine residues in
peptides and proteins. The oligonucleotide-peptide conjugate
migration distance was delayed as compared to non-modi¢ed
oligonucleotide migration distance (Fig. 2, lane 2). The oligo-
nucleotide-peptide conjugate migration distance was modi¢ed
after proteolytic treatment using trypsin (Fig. 2, lane 3). Poly-
acrylamide gel electrophoresis indicated incomplete proteoly-
sis of the oligonucleotide-peptide conjugates. Similar results
were obtained with the GA19-NLS conjugate (data not
shown).
3.3. Covalent triple helix formation between oligonucleotide-
peptide conjugates and plasmid
The e⁄ciency of triple helix formation and photoactivation
was studied on plasmid using the psoralen-oligonucleotide-
peptide conjugate. Pso-GA19-NLS conjugate and plasmid
were mixed with a molar conjugate/plasmid excess varying
between 15 and 200. After triple helix formation and irradi-
ation, the plasmid was digested with the two endonucleases
MfeI and SpeI. The digestion released a 70 bp fragment con-
taining the triple helix site. On a denaturing polyacrylamide
gel, this 70 bp plasmid fragment, when covalently associated
with an oligonucleotide-peptide conjugate, has a shorter dis-
tance of migration than the non-associated fragment. With an
excess of Pso-GA19-NLS conjugate/plasmid of 15, all plasmid
could be covalently associated with a Pso-GA19-NLS conju-
gate (Fig. 3, lane 2). Without photoactivation, no covalent
association could be detected in the same conditions after
electrophoresis in denaturing conditions (Fig. 3, lane 8). The
speci¢city of the psoralen reaction at the duplex-triplex junc-
Fig. 2. Characterization of oligonucleotide-NLS peptide conjugates.
Pso-GA19 oligonucleotide (lane 1), Pso-GA19-NLS conjugate (lane
2), Pso-GA19-NLS treated with trypsin (lane 3) were analyzed by
15% denaturing polyacrylamide gel electrophoresis and silver stain-
ing.
Fig. 3. Triple helix formation. Pso-GA19-NLS conjugate and plas-
mid were incubated overnight at 37‡C in 100 mM Tris-HCl pH 7.5,
50 mM MgCl2. Molar excess (conjugate/plasmid) was 15 (lane 2),
50 (lanes 3 and 8), 100 (lane 4), 200 (lane 5). Plasmid alone (lane 1)
and oligonucleotide alone (lanes 6 and 7) were used as controls.
After triple helix formation, the samples were irradiated except for
lanes 7 and 8, then digested with two endonucleases, MfeI and
SpeI, and analyzed by 15% denaturing polyacrylamide gel electro-
phoresis and silver staining.
Fig. 4. Transgene expression after transfection of plasmid-NLS con-
jugate. Non-modi¢ed plasmid (1) and plasmid covalently modi¢ed
with Pso-GA19-NLS conjugate (2) were used for transfecting NIH
3T3 cells with cationic lipid RPR 120535. No plasmid was used in
3. The L-galactosidase expression was evaluated after 24 h of incu-
bation. Values are means þ S.D. (n = 3).
Fig. 5. Interaction between importin K-GST and oligonucleotide-
NLS peptide conjugates. Immobilized importin K-GST (2 Wg) was
incubated for 30 min at room temperature with Pso-GA19 (2 Wg)
(lanes 3 and 4), Pso-GA19-NLS (lanes 5 and 6). Free Pso-GA19
(lane 1), free Pso-GA19-NLS (lane 2) and fractions bound to impor-
tin K-GST (lanes 4 and 6) and unbound (lanes 3 and 5) were ana-
lyzed by 15% denaturing polyacrylamide gel electrophoresis and sil-
ver staining.
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tion directed by oligonucleotide binding to its target sequence
was con¢rmed: plasmid covalently modi¢ed by triple helix
formation and non-modi¢ed plasmid were digested with var-
ious endonucleases and the digestion products compared on a
denaturing polyacrylamide gel (data not shown).
3.4. Transfection with peptide-plasmid conjugate
The functionality of the reporter plasmid was studied after
transfection of NIH 3T3 cells using a lipopolyamine, RPR
120535 [13]. Plasmid covalently associated with Pso-GA19-
NLS conjugate by triple helix formation and irradiation led
to L-galactosidase expression (Fig. 4). The increase in expres-
sion over non-modi¢ed plasmid was not signi¢cant.
3.5. Importin K binding assay
Binding of the oligonucleotide-peptide conjugate to impor-
tin K was studied using the importin K-GST fusion protein
binding assay with glutathione-Sepharose beads, followed by
polyacrylamide gel electrophoresis. Pso-GA19-NLS conjugate
was detected in the bound fraction (interacting with the im-
portin K-GST beads) whereas Pso-GA19 oligonucleotide was
recovered in the supernatant (Fig. 5). Similar results were
obtained with GA19-NLS conjugate and GA19 oligonucleotide
(data not shown). However, using the same assay, we could
not detect binding to importin K of the plasmid covalently
associated with Pso-GA19-NLS conjugate by triple helix for-
mation and irradiation (data not shown).
4. Discussion
Several methods for covalent attachment of molecules to
nucleic acids have been developed and reported so far
[11,12,15,16]. Among them, the use of photoactive molecules
leads to e⁄cient but non-speci¢c covalent modi¢cation of
DNA [12,17]. A suitable method for site-speci¢c labeling of
plasmid DNA involves the formation of a triple helix consist-
ing of an oligonucleotide bound within the major groove of a
double-stranded target sequence [18]. The triple helix used in
our study was based on oligopurine probes. The oligonucleo-
tide binds in an antiparallel orientation with respect to the
duplex DNA [19].
Psoralen-based reactions can be used to form covalent links
at the end of double helices [20], to attach triple helix forming
oligonucleotides to speci¢c sites in DNA [21], to inhibit gene
expression [22], or to perform targeted DNA mutagenesis [23].
The interstrand crosslinks are between the furan or the pyrone
sides of the psoralen and the 5-6 double bond of one or two
thymines in the DNA [23]. The psoralen preferred reaction
sites are 5P-TpA or 5P-ApT. We constructed a plasmid con-
taining a triple helix target site adjacent to the psoralen reac-
tion site, upstream of the transgene expression cassette, and
used a GA-rich oligonucleotide to form a triple helix at the
target site. Using a psoralen-oligonucleotide conjugate thus
makes it possible to form a covalent triple helix at a speci¢c
site.
Covalent attachment of molecules to oligonucleotides is de-
veloped in order to promote the uptake of oligonucleotides by
cells, and/or to improve their resistance to nucleases. The
preparation of oligonucleotide-peptide conjugates presents a
challenge because the two molecules, oligonucleotide and pep-
tide, have di¡erent chemical stability conditions. Di¡erent
methods have been described [14]. We decided to couple a
puri¢ed oligonucleotide modi¢ed with a thiol residue to a
NLS peptide bearing a maleimide group. Oligonucleotides
with or without a psoralen group were easily coupled to the
NLS peptide.
Using a binding assay, we showed that Pso-GA19-NLS and
GA19-NLS conjugates interacted with the NLS binding pro-
tein, importin K. Our results show that NLS peptides are
recognized, in spite of the oligonucleotide electrostatic proper-
ties.
Pso-GA19-NLS conjugate could form a stable and covalent
triple helix with the plasmid target site, and a low molar
excess of conjugate was needed. The modi¢ed plasmid ex-
pressed the transgene at the same level as non-modi¢ed plas-
mid. This was consistent with the working hypothesis of in-
serting the triple helix target site upstream of the transgene
expression cassette.
In a previous study, we attached several NLS peptides to
plasmid DNA by photoactivation using a p-azido-tetra£uoro-
benzyl-NLS peptide conjugate, and showed that the modi¢ed
plasmid could interact with importin K using the same binding
assay [12]. At least 10 NLS peptides must be attached per
plasmid DNA in order to detect association of the conjugates
with importin K [12]. Since the conjugates used in the present
Scheme 1. Synthesis of oligonucleotide-NLS peptide conjugates. The scheme illustrates synthesis using Pso-GA19-SH oligonucleotide and NLS
peptide.
Table 1
Oligonucleotides used
Oligonucleotide Modi¢cation(s)
GA19 none
GA19-SH thiol group at the 5P terminus
Pso-GA19 psoralen group at the 5P terminus
Pso-GA19-SH psoralen group at the 5P terminus, thiol group
at the 3P terminus
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study bear only one NLS peptide per plasmid DNA, it is
consistent that their interaction with importin K could not
be observed, being under the detection limit.
We did not observe any signi¢cant increase in expression as
a result of the NLS peptide. In a recent study [24], transfec-
tion enhancement was observed using a capped 3.3 kb linear
plasmid tagged with a single nuclear localization signal pep-
tide. We covalently coupled one NLS peptide to plasmid
DNA by a di¡erent method and chose to keep plasmid integ-
rity and size. These di¡erences can explain why we did not
observe any signi¢cant e¡ect on transfection e⁄ciency.
In conclusion, we have designed a novel simple method for
covalently coupling one NLS peptide to plasmid DNA using a
triple helix. This technology makes it possible to control the
number of peptides linked to DNA, which is strictly depend-
ent on the number of inserted triple helix-forming sequences,
and to control also the site of association, which is determi-
nant for maintaining plasmid integrity and expression. The
modi¢ed plasmid can be produced on a large scale. Moreover,
we show in the present work that oligonucleotide-NLS pep-
tide conjugates are recognized by the importin K NLS recep-
tor. The present strategy could be used for coupling other
ligands to plasmid DNA, and to study plasmid-ligand conju-
gate interaction with receptors, while maintaining transgene
expression.
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